US research funding stalls as Congress delays grants, raising innovation concerns
Congressional hold on approved research grants is delaying university projects, while China has overtaken the US in total research spending.
The Association of American Universities notes a second consecutive year of reduced doctoral admissions, linked to grants being halted for political review despite prior congressional approval. A White House budget office plan to let agencies cancel grants without hearings sparked more than 90% negative feedback in a half-million-response public comment period, and was rejected by the Senate (90-6) and the House (370-48), though the prohibition lifts in December.
The National Science Foundation has already cut new grants by over 40%, freezing about 50 medical trials and leaving roughly 7,500 patients unable to enroll. These delays threaten the pipeline of future scientists and could erode the United States’ historic lead in innovation. In 2024, China out-spent the US in research, reaching $1.03 trillion versus $1.01 trillion, underscoring the competitive stakes.
Why it matters
Stalled federal research funding could weaken US scientific leadership and delay medical advances.
In this story
